Selective drug transport and P-glycoprotein activity in an in vitro blood-brain barrier model (original) (raw)

Evaluation of the immortalised mouse brain capillary endothelial cell line, b.End3, as an in vitro blood–brain barrier model for drug uptake and transport studies

Mark Gumbleton

Brain Research, 2003

View PDFchevron_right

Comparison of a Rat Primary Cell-Based Blood-Brain Barrier Model With Epithelial and Brain Endothelial Cell Lines: Gene Expression and Drug Transport

Gábor Rákhely

Frontiers in molecular neuroscience, 2018

View PDFchevron_right

In Situ Transport of Vinblastine and Selected P-glycoprotein Substrates: Implications for Drug-Drug Interactions at the Mouse Blood-Brain Barrier

Salvatore Cisternino

Pharmaceutical Research, 2000

View PDFchevron_right

Screening of multidrug-resistance sensitive drugs by in situ brain perfusion in P-glycoprotein-deficient mice

Salvatore Cisternino

Pharmaceutical research, 2001

View PDFchevron_right

The human brain endothelial cell line hCMEC/D3 as a human blood-brain barrier model for drug transport studies

Babette Weksler

Journal of Neurochemistry, 2008

View PDFchevron_right

Evaluation of the MDR-MDCK cell line as a permeability screen for the blood–brain barrier

Ismael Hidalgo

International Journal of Pharmaceutics, 2005

View PDFchevron_right

Drug transport to the brain: in vitro versus in vivo approaches

Elizabeth CM de Lange

Journal of Controlled Release, 1994

View PDFchevron_right

Permeability of Endothelial and Astrocyte Cocultures: In Vitro Blood–Brain Barrier Models for Drug Delivery Studies

Bingmei Fu

Annals of Biomedical Engineering, 2010

View PDFchevron_right

Pharmacokinetics of P-glycoprotein inhibition in the rat blood-brain barrier

Obaidur Rahman

Journal of Pharmaceutical Sciences, 2008

View PDFchevron_right

Transport Rankings of Non-Steroidal Antiinflammatory Drugs across Blood-Brain Barrier In Vitro Models

Bodo Lachmann

PLoS ONE, 2014

View PDFchevron_right

A method to determine the ability of drugs to diffuse through the blood-brain barrier

Anna Seelig

Proceedings of the National Academy of Sciences, 1994

View PDFchevron_right

Evaluation of the immortalized human brain capillary endothelial cell line BB19 as a human cell culture model for the blood–brain barrier

Juergen Drewe

Brain Research, 2005

View PDFchevron_right

IVIVC Assessment of Two Mouse Brain Endothelial Cell Models for Drug Screening

Gaëlle ROULLIN

Pharmaceutics

View PDFchevron_right

PET Studies on P-glycoprotein function in the blood-brain barrier: how it affects uptake and binding of drugs within the CNS

Aren van Waarde

2004

View PDFchevron_right

Verapamil P-glycoprotein Transport across the Rat Blood-Brain Barrier: Cyclosporine, a Concentration Inhibition Analysis, and Comparison with Human Data

Peng Hsiao

Journal of Pharmacology and Experimental Therapeutics, 2006

View PDFchevron_right

Quantitative assessment of P-glycoprotein function in the rat blood–brain barrier by distribution volume of [11C]verapamil measured with PET

Harry Groen

NeuroImage, 2003

View PDFchevron_right

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites

Carlos Cordon-cardo

Proceedings of the National Academy of Sciences, 1989

View PDFchevron_right

Drug transport across the blood–brain barrier

Joost van Bree

Journal of Cerebral Blood Flow & Metabolism, 2012

View PDFchevron_right

vitro to in vivo prediction of P-glycoprotein based drug interactions at the human and rodent blood-brain barrier. Drug Metab Dispos

Peng Hsiao

2020

View PDFchevron_right

A new blood–brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes

Ágnes Kittel

Neurochemistry International, 2009

View PDFchevron_right

Comparison of in vitro cell models in predicting in vivo brain entry of drugs

Juho Hokkanen

International journal of pharmaceutics, 2010

View PDFchevron_right

An in vitro Model for Blood Brain Barrier Permeation

Christian Noe

Scientia Pharmaceutica

View PDFchevron_right

Marjukka Suhonen

International journal of pharmaceutics, 2012

View PDFchevron_right

Drug targeting to brain: A systematic approach to study the factors, parameters and approaches for prediction of permeability of drugs across BBB

kalpana nagpal

Expert Opinion on Drug Delivery, 2013

View PDFchevron_right

In vivo saturation of the transport of vinblastine and colchicine by P-glycoprotein at the rat blood-brain barrier

Salvatore Cisternino

Pharmaceutical research, 2003

View PDFchevron_right

In-vitro blood-brain barrier models for drug screening and permeation studies: an overview

Sounak Bagchi

Drug Design, Development and Therapy

View PDFchevron_right

Expression of Tight Junction and Drug Efflux Transporter Proteins in an in vitro Model of Human Blood–Brain Barrier

Giuseppe Oliveri

Frontiers in Psychiatry, 2012

View PDFchevron_right

In vitro models for the blood–brain barrier

Thomas Osterberg

Toxicology in Vitro, 2005

View PDFchevron_right

The Role of Size and Charge for Blood–Brain Barrier Permeation of Drugs and Fatty Acids

Anna Seelig

Journal of Molecular Neuroscience, 2007

View PDFchevron_right

Inhibition of P-glycoprotein enhances transport of imipramine across the blood-brain barrier: microdialysis studies in conscious freely moving rats

Brendan Griffin, Ted Dinan

British Journal of Pharmacology, 2012

View PDFchevron_right

Brain uptake and anticancer activities of vincristine and vinblastine are restricted by their low cerebrovascular permeability and binding to plasma constituents in rat

Nigel Greig

Cancer Chemotherapy and Pharmacology, 1990

View PDFchevron_right

Effect of Tacrolimus on Activity and Expression of P-Glycoprotein and ATP-Binding Cassette Transporter A5 (ABCA5) Proteins in Hematoencephalic Barrier Cells

Alejandro Yañez

Biological and Pharmaceutical Bulletin, 2008

View PDFchevron_right

Selective drug transport and P-glycoprotein activity in an in vitro blood-brain barrier model (original) (raw)

Related papers